Page last updated: 2024-08-21

thiazolidines and Cardiovascular Diseases

thiazolidines has been researched along with Cardiovascular Diseases in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (20.00)18.2507
2000's4 (40.00)29.6817
2010's3 (30.00)24.3611
2020's1 (10.00)2.80

Authors

AuthorsStudies
Hatware, K; Patil, K; Sharma, R; Sharma, S1
Morishita, R; Nakagami, H1
Domergue, J; Haufroid, V; Lison, D1
Bhatt, DL; De Rycke, Y; Hajage, D; Steg, PG; Tubach, F1
Rapezzi, C; Volpe, M1
Silacci, P1
Kawakami, M; Kuroki, M1
Gross, B; Staels, B1
Nakamura, T; Okano, R; Okuda, S; Seo, Y; Uchiyama, H1
Ikeda, T; Iwata, K; Tanaka, Y1

Reviews

5 review(s) available for thiazolidines and Cardiovascular Diseases

ArticleYear
Review on Chemistry, Analysis and Pharmacology of Teneligliptin: A Novel DPP-4 Inhibitor.
    Mini reviews in medicinal chemistry, 2020, Volume: 20, Issue:12

    Topics: Blood Glucose; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Drug Interactions; Glucagon-Like Peptide 1; Half-Life; Humans; Pyrazoles; Thiazolidines

2020
Teneligliptin : expectations for its pleiotropic action.
    Expert opinion on pharmacotherapy, 2015, Volume: 16, Issue:3

    Topics: Blood Glucose; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Humans; Hyperglycemia; Hypoglycemia; Hypoglycemic Agents; Pyrazoles; Thiazolidines

2015
Advanced glycation end-products as a potential target for treatment of cardiovascular disease.
    Journal of hypertension, 2002, Volume: 20, Issue:8

    Topics: Animals; Cardiovascular Diseases; Glycation End Products, Advanced; Humans; Hypertension; Rats; Thiadiazoles; Thiazolidines

2002
[Aminoguanidine and other AGE inhibitors].
    Nihon rinsho. Japanese journal of clinical medicine, 2002, Volume: 60 Suppl 9

    Topics: Amides; Animals; Arteriosclerosis; Cardiovascular Diseases; Cataract; Clinical Trials as Topic; Diabetes Mellitus; Diabetic Nephropathies; Diabetic Retinopathy; Disease Models, Animal; Drug Design; Glycation End Products, Advanced; Guanidines; Humans; Hydrazines; Hypoglycemic Agents; Thiadiazoles; Thiazoles; Thiazolidines

2002
PPAR agonists: multimodal drugs for the treatment of type-2 diabetes.
    Best practice & research. Clinical endocrinology & metabolism, 2007, Volume: 21, Issue:4

    Topics: Animals; Blood Glucose; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Homeostasis; Humans; Insulin; Insulin Resistance; Lipid Metabolism; Lipoproteins; Peroxisome Proliferator-Activated Receptors; PPAR alpha; PPAR delta; PPAR gamma; Thiazolidines

2007

Trials

1 trial(s) available for thiazolidines and Cardiovascular Diseases

ArticleYear
Long-term effect of epalrestat on cardiac autonomic neuropathy in subjects with non-insulin dependent diabetes mellitus.
    Diabetes research and clinical practice, 1999, Volume: 43, Issue:3

    Topics: Aged; Aged, 80 and over; Aldehyde Reductase; Autonomic Nervous System Diseases; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Electrocardiography; Enzyme Inhibitors; Female; Humans; Male; Middle Aged; Rhodanine; Statistics, Nonparametric; Thiazolidines

1999

Other Studies

4 other study(ies) available for thiazolidines and Cardiovascular Diseases

ArticleYear
No evidence of cardiovascular toxicity in workers exposed below 5 ppm carbon disulfide.
    International archives of occupational and environmental health, 2016, Volume: 89, Issue:5

    Topics: Adult; Biomarkers; C-Reactive Protein; Carbon Disulfide; Cardiotoxicity; Cardiovascular Diseases; Chemical Industry; Cholesterol; Cross-Sectional Studies; Environmental Monitoring; Humans; Middle Aged; Occupational Diseases; Occupational Exposure; Regression Analysis; Risk Factors; Thiazolidines; Time; Young Adult

2016
On the use of propensity scores in case of rare exposure.
    BMC medical research methodology, 2016, Mar-31, Volume: 16

    Topics: Cardiovascular Diseases; Computer Simulation; Female; Humans; Male; Models, Statistical; Monte Carlo Method; Observational Studies as Topic; Propensity Score; Proportional Hazards Models; Thiazolidines

2016
[Residual risk in cardiovascular prevention].
    Giornale italiano di cardiologia (2006), 2008, Volume: 9, Issue:4 Suppl 1

    Topics: Atherosclerosis; Blood Pressure; Body Weight; Cannabinoid Receptor Antagonists; Cannabinoids; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Follow-Up Studies; Humans; Hypolipidemic Agents; Kaplan-Meier Estimate; Piperidines; Pyrazoles; Randomized Controlled Trials as Topic; Rimonabant; Risk Factors; Smoking Cessation; Thiazolidines; Time Factors

2008
Effectiveness of aldose reductase inhibitors for diabetic gastroenteropathy with constipation.
    Internal medicine (Tokyo, Japan), 1997, Volume: 36, Issue:7

    Topics: Aldehyde Reductase; Autonomic Nervous System Diseases; Cardiovascular Diseases; Constipation; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Enzyme Inhibitors; Female; Gastrointestinal Motility; Hemodynamics; Humans; Intestinal Pseudo-Obstruction; Middle Aged; Rhodanine; Shock, Septic; Thiazolidines

1997